129 related articles for article (PubMed ID: 150858)
1. A method using fibrin-fixed Blue Dextran for determining the plasmin and plasmin inhibitor activities in human plasma.
Tamura Y; Otsuka A; Sone K; Sakurai E; Mori H; Sumi H; Kosugi T; Fujii S
Biochim Biophys Acta; 1978 Jul; 525(1):194-9. PubMed ID: 150858
[TBL] [Abstract][Full Text] [Related]
2. A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin.
Moroz LA; Gilmore NJ
Blood; 1975 Oct; 46(4):543-53. PubMed ID: 126094
[TBL] [Abstract][Full Text] [Related]
3. Different molecular forms of plasminogen and plasmin produced by urokinase in human plasma and their relation to protease inhibitors and lysis of fibrinogen and fibrin.
Müllertz S
Biochem J; 1974 Nov; 143(2):273-83. PubMed ID: 4282470
[TBL] [Abstract][Full Text] [Related]
4. Fibrin suspension as a substrate fop plasmin: determination and kinetics.
Kanai S; Okamoto H; Tamaura Y; Yamazaki S; Inada Y
Thromb Haemost; 1979 Dec; 42(4):1153-8. PubMed ID: 161668
[TBL] [Abstract][Full Text] [Related]
5. Alpha2-plasmin inhibitor and alpha2-macroglobulin-plasmin complexes in plasma. Quantitation by an enzyme-linked differential antibody immunosorbent assay.
Harpel PC
J Clin Invest; 1981 Jul; 68(1):46-55. PubMed ID: 6166634
[TBL] [Abstract][Full Text] [Related]
6. The interaction of C1-esterase inhibitor and plasmin in human euglobulin.
Highsmith RF; Burnett CJ; Weirich CJ
J Lab Clin Med; 1979 Mar; 93(3):459-71. PubMed ID: 155127
[No Abstract] [Full Text] [Related]
7. [Index of fibrinolysis with new fibrin plate (author's transl)].
Hishikawa Y; Sugie I
Nihon Seirigaku Zasshi; 1977; 39(1):1-11. PubMed ID: 140239
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of fibrinolytic therapy by measuring cross-linked fibrin derivatives and plasmin-alpha 2-plasmin inhibitor complex in plasma.
Takahashi H; Takizawa S; Hanano M; Tatewaki W; Nagasaki Y; Sasagawa Y; Shibata A
Tohoku J Exp Med; 1987 Dec; 153(4):295-302. PubMed ID: 2964745
[TBL] [Abstract][Full Text] [Related]
9. An analysis of the activators of single-chain urokinase-type plasminogen activator (scu-PA) in the dextran sulphate euglobulin fraction of normal plasma and of plasmas deficient in factor XII and prekallikrein.
Binnema DJ; Dooijewaard G; Turion PN
Thromb Haemost; 1991 Feb; 65(2):144-8. PubMed ID: 1905069
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
Moroz LA; Gilmore NJ
Blood; 1976 Oct; 48(4):531-45. PubMed ID: 134751
[TBL] [Abstract][Full Text] [Related]
11. Fibrinolysis in health and disease: severe abnormalities in systemic lupus erythematosus.
Glas-Greenwalt P; Kant KS; Allen C; Pollak VE
J Lab Clin Med; 1984 Dec; 104(6):962-76. PubMed ID: 6239000
[TBL] [Abstract][Full Text] [Related]
12. Plasmin potency estimates: influence of the substrate used in assay.
Philo RD; Gaffney PJ
Thromb Haemost; 1981 Apr; 45(2):107-9. PubMed ID: 6454987
[TBL] [Abstract][Full Text] [Related]
13. The behavior of alpha2-plasmin inhibitor in fibrinolytic states.
Aoki N; Moroi M; Matsuda M; Tachiya K
J Clin Invest; 1977 Aug; 60(2):361-9. PubMed ID: 68962
[TBL] [Abstract][Full Text] [Related]
14. Fibrinolysis and thrombosis of fibrinogen-modified gold nanoparticles for detection of fibrinolytic-related proteins.
Jian JW; Chiu WC; Chang HT; Hsu PH; Huang CC
Anal Chim Acta; 2013 Apr; 774():67-72. PubMed ID: 23567118
[TBL] [Abstract][Full Text] [Related]
15. Sequence of formation of molecular forms of plasminogen and plasmin-inhibitor complexes in plasma activated by urokinase or tissue-type plasminogen activator.
Thorsen S; Müllertz S; Suenson E; Kok P
Biochem J; 1984 Oct; 223(1):179-87. PubMed ID: 6208894
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
Cheng AC; Tsai IH
Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
[TBL] [Abstract][Full Text] [Related]
17. Quantitative determination of plasmin: a fibrinogenolytic method.
Vukovich T
Clin Chim Acta; 1977 Sep; 79(2):285-90. PubMed ID: 142589
[TBL] [Abstract][Full Text] [Related]
18. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
19. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
20. A delaying influence of cryoglobulins in the assessment of euglobulin fibrinolytic activity.
Gram J; Jespersen J; Astrup T
Thromb Res; 1986 Mar; 41(6):781-9. PubMed ID: 2422781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]